Cargando…

Role of Patient and Practice Characteristics in Variance of Treatment Quality in Type 2 Diabetes between General Practices

BACKGROUND: Accounting for justifiable variance is important for fair comparisons of treatment quality. The variance between general practices in treatment quality of type 2 diabetes (T2DM) patients may be attributed to the underlying patient population and practice characteristics. The objective of...

Descripción completa

Detalles Bibliográficos
Autores principales: Cho, Yeon Young, Sidorenkov, Grigory, Denig, Petra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5091743/
https://www.ncbi.nlm.nih.gov/pubmed/27806107
http://dx.doi.org/10.1371/journal.pone.0166012
_version_ 1782464627005718528
author Cho, Yeon Young
Sidorenkov, Grigory
Denig, Petra
author_facet Cho, Yeon Young
Sidorenkov, Grigory
Denig, Petra
author_sort Cho, Yeon Young
collection PubMed
description BACKGROUND: Accounting for justifiable variance is important for fair comparisons of treatment quality. The variance between general practices in treatment quality of type 2 diabetes (T2DM) patients may be attributed to the underlying patient population and practice characteristics. The objective of this study is to describe the between practice differences in treatment, and identify patient and practice level characteristics that may explain these differences. METHODS: The data of 24,607 T2DM patients from 183 general practices in the Netherlands were used. Treatment variance was assessed in a cross-sectional manner for: glucose-lowering drugs/metformin, lipid-lowering drugs/statins, blood pressure-lowering drugs/ACE-inhibitor or ARB. Patient characteristics tested were age, gender, diabetes duration, comorbidity, comedication. Practice characteristics were number of T2DM patients, practice type, diabetes assistant available. Multilevel logistic regression was used to examine the between practice variance in treatment and the effect of characteristics on this variance. RESULTS: Treatment rates varied considerably between practices (IQR 9.5–13.9). The variance at practice level was 7.5% for glucose-lowering drugs, 3.6% for metformin, 3.1% for lipid-lowering drugs, 10.3% for statins, 8.6% for blood pressure-lowering drugs, and 3.9% for ACE-inhibitor/ARB. Patient and practice characteristics explained 19.0%, 7.5%, 20%, 6%, 9.9%, and 13.4% of the variance respectively. Age, multiple chronic drugs, and ≥3 glucose-lowering drugs were the most relevant patient characteristics. Number of T2DM patients per practice was the most relevant practice characteristic. DISCUSSION: Considerable differences exist between practices in treatment rates. Patients’ age was identified as characteristic that may account for justifiable differences in especially lipid-lowering treatment. Other patient or practice characteristics either do not explain or do not justify the differences.
format Online
Article
Text
id pubmed-5091743
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-50917432016-11-15 Role of Patient and Practice Characteristics in Variance of Treatment Quality in Type 2 Diabetes between General Practices Cho, Yeon Young Sidorenkov, Grigory Denig, Petra PLoS One Research Article BACKGROUND: Accounting for justifiable variance is important for fair comparisons of treatment quality. The variance between general practices in treatment quality of type 2 diabetes (T2DM) patients may be attributed to the underlying patient population and practice characteristics. The objective of this study is to describe the between practice differences in treatment, and identify patient and practice level characteristics that may explain these differences. METHODS: The data of 24,607 T2DM patients from 183 general practices in the Netherlands were used. Treatment variance was assessed in a cross-sectional manner for: glucose-lowering drugs/metformin, lipid-lowering drugs/statins, blood pressure-lowering drugs/ACE-inhibitor or ARB. Patient characteristics tested were age, gender, diabetes duration, comorbidity, comedication. Practice characteristics were number of T2DM patients, practice type, diabetes assistant available. Multilevel logistic regression was used to examine the between practice variance in treatment and the effect of characteristics on this variance. RESULTS: Treatment rates varied considerably between practices (IQR 9.5–13.9). The variance at practice level was 7.5% for glucose-lowering drugs, 3.6% for metformin, 3.1% for lipid-lowering drugs, 10.3% for statins, 8.6% for blood pressure-lowering drugs, and 3.9% for ACE-inhibitor/ARB. Patient and practice characteristics explained 19.0%, 7.5%, 20%, 6%, 9.9%, and 13.4% of the variance respectively. Age, multiple chronic drugs, and ≥3 glucose-lowering drugs were the most relevant patient characteristics. Number of T2DM patients per practice was the most relevant practice characteristic. DISCUSSION: Considerable differences exist between practices in treatment rates. Patients’ age was identified as characteristic that may account for justifiable differences in especially lipid-lowering treatment. Other patient or practice characteristics either do not explain or do not justify the differences. Public Library of Science 2016-11-02 /pmc/articles/PMC5091743/ /pubmed/27806107 http://dx.doi.org/10.1371/journal.pone.0166012 Text en © 2016 Cho et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Cho, Yeon Young
Sidorenkov, Grigory
Denig, Petra
Role of Patient and Practice Characteristics in Variance of Treatment Quality in Type 2 Diabetes between General Practices
title Role of Patient and Practice Characteristics in Variance of Treatment Quality in Type 2 Diabetes between General Practices
title_full Role of Patient and Practice Characteristics in Variance of Treatment Quality in Type 2 Diabetes between General Practices
title_fullStr Role of Patient and Practice Characteristics in Variance of Treatment Quality in Type 2 Diabetes between General Practices
title_full_unstemmed Role of Patient and Practice Characteristics in Variance of Treatment Quality in Type 2 Diabetes between General Practices
title_short Role of Patient and Practice Characteristics in Variance of Treatment Quality in Type 2 Diabetes between General Practices
title_sort role of patient and practice characteristics in variance of treatment quality in type 2 diabetes between general practices
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5091743/
https://www.ncbi.nlm.nih.gov/pubmed/27806107
http://dx.doi.org/10.1371/journal.pone.0166012
work_keys_str_mv AT choyeonyoung roleofpatientandpracticecharacteristicsinvarianceoftreatmentqualityintype2diabetesbetweengeneralpractices
AT sidorenkovgrigory roleofpatientandpracticecharacteristicsinvarianceoftreatmentqualityintype2diabetesbetweengeneralpractices
AT denigpetra roleofpatientandpracticecharacteristicsinvarianceoftreatmentqualityintype2diabetesbetweengeneralpractices